Connection

Andy Goren to Androgen Antagonists

Back to Details
This is a "connection" page, showing publications Andy Goren has written about Androgen Antagonists.
Andy Goren
Connection Strength
1.879
Androgen Antagonists
  1. Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men. J Eur Acad Dermatol Venereol. 2021 Jan; 35(1):e13-e15.
    View in: PubMed
    Score: 0.633
  2. Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19? J Cosmet Dermatol. 2020 Jul; 19(7):1542-1543.
    View in: PubMed
    Score: 0.618
  3. Potential risk for developing severe COVID-19 disease among anabolic steroid users. BMJ Case Rep. 2021 Feb 26; 14(2).
    View in: PubMed
    Score: 0.162
  4. Androgen sensitivity in COVID-19 and antiandrogens: Prospective data are still needed. Dermatol Ther. 2020 11; 33(6):e14166.
    View in: PubMed
    Score: 0.157
  5. Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS). Med Hypotheses. 2020 Oct; 143:110112.
    View in: PubMed
    Score: 0.155
  6. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign". J Am Acad Dermatol. 2020 Aug; 83(2):680-682.
    View in: PubMed
    Score: 0.154
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.